175 related articles for article (PubMed ID: 34374651)
1. Long-term morbidity and mortality in patients diagnosed with an insulinoma.
Peltola E; Hannula P; Huhtala H; Metso S; Sand J; Laukkarinen J; Tiikkainen M; Sirén J; Soinio M; Nuutila P; Moilanen L; Laaksonen DE; Ebeling T; Arola J; Schalin-Jäntti C; Jaatinen P
Eur J Endocrinol; 2021 Sep; 185(4):577-586. PubMed ID: 34374651
[TBL] [Abstract][Full Text] [Related]
2. Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study.
Service FJ; McMahon MM; O'Brien PC; Ballard DJ
Mayo Clin Proc; 1991 Jul; 66(7):711-9. PubMed ID: 1677058
[TBL] [Abstract][Full Text] [Related]
3. [Insulinomas in Tampere University Hospital Special Responsibility Area in 1980-2010].
Uitto E; Hannula P; Metso S; Vornanen M; Sand J; Jaatinen P
Duodecim; 2015; 131(17):1598-604. PubMed ID: 26548107
[TBL] [Abstract][Full Text] [Related]
4. Surgery for multiple endocrine neoplasia type 1-related insulinoma: long-term outcomes in a large international cohort.
van Beek DJ; Nell S; Verkooijen HM; Borel Rinkes IHM; Valk GD; ; Vriens MR;
Br J Surg; 2020 Oct; 107(11):1489-1499. PubMed ID: 32352164
[TBL] [Abstract][Full Text] [Related]
5. Comparison Between Sporadic and Multiple Endocrine Neoplasia Type 1-Associated Insulinoma.
Sada A; Habermann EB; Szabo Yamashita T; Thompson GB; Lyden ML; Foster TR; Dy BM; Halfdanarson TR; Vella A; McKenzie TJ
J Am Coll Surg; 2022 Nov; 235(5):756-763. PubMed ID: 35752874
[TBL] [Abstract][Full Text] [Related]
6. Insulinoma: a rare neuroendocrine pancreatic tumor.
Stamatakos M; Safioleas C; Tsaknaki S; Safioleas P; Iannescu R; Safioleas M
Chirurgia (Bucur); 2009; 104(6):669-73. PubMed ID: 20187464
[TBL] [Abstract][Full Text] [Related]
7. Assessing the short- and long-term outcomes after resection of benign insulinoma.
Tsang YP; Lang BH; Shek TW
ANZ J Surg; 2016 Sep; 86(9):706-10. PubMed ID: 25345822
[TBL] [Abstract][Full Text] [Related]
8. Insulinoma: a multicenter, retrospective analysis of three decades of experience (1983-2014).
Iglesias P; Lafuente C; Martín Almendra MÁ; López Guzmán A; Castro JC; Díez JJ
Endocrinol Nutr; 2015; 62(7):306-13. PubMed ID: 26050581
[TBL] [Abstract][Full Text] [Related]
9. Increased EpCAM expression in malignant insulinoma: potential clinical implications.
Raffel A; Eisenberger CF; Cupisti K; Schott M; Baldus SE; Hoffmann I; Aydin F; Knoefel WT; Stoecklein NH
Eur J Endocrinol; 2010 Feb; 162(2):391-8. PubMed ID: 20097833
[TBL] [Abstract][Full Text] [Related]
10. DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients.
Jonkers YM; Claessen SM; Perren A; Schmitt AM; Hofland LJ; de Herder W; de Krijger RR; Verhofstad AA; Hermus AR; Kummer JA; Skogseid B; Volante M; Voogd AC; Ramaekers FC; Speel EJ
Endocr Relat Cancer; 2007 Sep; 14(3):769-79. PubMed ID: 17914106
[TBL] [Abstract][Full Text] [Related]
11. [Pancreatic endocrine tumors].
Târcoveanu E; Moldovanu R; Georgescu S; Niculescu D; Lupaşcu C; Dimofte G
Chirurgia (Bucur); 2006; 101(2):175-81. PubMed ID: 16752684
[TBL] [Abstract][Full Text] [Related]
12. Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts General Hospital.
Nikfarjam M; Warshaw AL; Axelrod L; Deshpande V; Thayer SP; Ferrone CR; Fernández-del Castillo C
Ann Surg; 2008 Jan; 247(1):165-72. PubMed ID: 18156937
[TBL] [Abstract][Full Text] [Related]
13. Surgical management of patients with insulinomas: Result of 292 cases in a single institution.
Zhao YP; Zhan HX; Zhang TP; Cong L; Dai MH; Liao Q; Cai LX
J Surg Oncol; 2011 Feb; 103(2):169-74. PubMed ID: 21259252
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological characteristics and non-adhesive organ culture of insulinomas.
Hoem D; Jensen D; Steine S; Thorsen TE; Viste A; Molven A
Scand J Surg; 2008; 97(1):42-9. PubMed ID: 18450205
[TBL] [Abstract][Full Text] [Related]
15. The surgical management of insulinoma.
Vázquez Quintana E
Bol Asoc Med P R; 2004; 96(1):33-8. PubMed ID: 15575328
[TBL] [Abstract][Full Text] [Related]
16. Insulinoma.
Grant CS
Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):783-98. PubMed ID: 16253900
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics and Incidences of Benign and Malignant Insulinoma Using a National Inpatient Database in Japan.
Kurakawa KI; Okada A; Manaka K; Konishi T; Jo T; Ono S; Uda K; Michihata N; Matsui H; Fushimi K; Yamaguchi S; Yamauchi T; Nangaku M; Yasunaga H; Kadowaki T
J Clin Endocrinol Metab; 2021 Nov; 106(12):3477-3486. PubMed ID: 34343300
[TBL] [Abstract][Full Text] [Related]
18. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
19. Surgery for gastrinoma and insulinoma in multiple endocrine neoplasia type 1.
Norton JA; Fang TD; Jensen RT
J Natl Compr Canc Netw; 2006 Feb; 4(2):148-53. PubMed ID: 16451771
[TBL] [Abstract][Full Text] [Related]
20. Enucleation and limited pancreatic resection provide long-term cure for insulinoma in multiple endocrine neoplasia type 1.
Bartsch DK; Albers M; Knoop R; Kann PH; Fendrich V; Waldmann J
Neuroendocrinology; 2013; 98(4):290-8. PubMed ID: 24356648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
